Israel Englander Regeneron Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 201,174 shares of REGN stock, worth $141 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

201,174

Previous 113,300 77.56%

Holding current value

$141 Million

Previous $119 Million 77.6%

% of portfolio

0.11%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $67.4 Million - $79.1 Million	-65,858 Reduced 24.66%	201,174 $211 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $59.9 Million - $72.7 Million	67,826 Added 34.05%	267,032 $281 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $73.2 Million - $80.5 Million	-81,075 Reduced 28.93%	199,206 $192 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $179 Million - $203 Million	230,622 Added 464.41%	280,281 $246 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $159 Million - $188 Million	-226,914 Reduced 82.04%	49,659 $35.7 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $165 Million - $201 Million	242,590 Added 713.86%	276,573 $227 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $16.1 Million - $17.5 Million	22,876 Added 205.96%	33,983 $24.5 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $2.82 Million - $3.55 Million	4,906 Added 79.12%	11,107 $7.65 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $12.3 Million - $16.6 Million	-22,484 Reduced 78.38%	6,201 $3.67 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $57.2 Million - $67.1 Million	-96,109 Reduced 77.01%	28,685 $20 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $30.1 Million - $37.1 Million	55,338 Added 79.67%	124,794 $78.8 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $66 Million - $78.3 Million	-115,035 Reduced 62.35%	69,456 $42 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $2.41 Million - $2.84 Million	-5,091 Reduced 2.69%	184,491 $103 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $2.15 Million - $2.63 Million	4,803 Added 2.6%	189,582 $89.7 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $82.1 Million - $104 Million	171,745 Added 1317.67%	184,779 $89.3 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $4.13 Million - $4.99 Million	7,588 Added 139.33%	13,034 $7.3 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $43.4 Million - $56.6 Million	-87,934 Reduced 94.17%	5,446 $3.4 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $1.82 Million - $2.68 Million	-5,426 Reduced 5.49%	93,380 $45.6 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $67.5 Million - $92.8 Million	-246,382 Reduced 71.38%	98,806 $37.1 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $35 Million - $40.8 Million	-128,130 Reduced 27.07%	345,188 $95.8 Million
Q2 2019 Aug 15, 2019	SELL	$299.6 - $414.82 $28.7 Million - $39.7 Million	-95,679 Reduced 16.82%	473,318 $148 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $160 Million - $222 Million	535,229 Added 1585.02%	568,997 $150 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $5.97 Million - $7.05 Million	16,033 Added 90.4%	33,768 $13.9 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $29.5 Million - $35.4 Million	-87,854 Reduced 83.2%	17,735 $6.62 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $11.5 Million - $13.3 Million	32,674 Added 44.81%	105,589 $42.7 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $36.8 Million - $44.7 Million	-129,431 Reduced 63.97%	72,915 $25.2 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $87.1 Million - $109 Million	-275,898 Reduced 57.69%	202,346 $69.7 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $99 Million - $130 Million	276,154 Added 136.65%	478,244 $180 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $87.2 Million - $102 Million	202,090	202,090 $90.4 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account